Reading the tape
NASDAQ: ALGN
Align Technology, Inc.
Healthcare · Medical - Devices
Market Cap
$12.09B
52w High
$208.31
52w Low
$122.00
P/E
28.04
Volume
830.40K
Outstanding Shares
71.62M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
1Y Price: -6.72%Revenue (TTM): 2.89%FCF (TTM): 8.78%P/FCF: 3rd pct
What changed
The stock fell 6.72% over the last year. Revenue grew 2.89% over the trailing twelve months. Operating margin moved from 14.69% to 14.44%. Free cash flow grew 8.78% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 14.44%. A decisive move in revenue — currently up 2.89% — would be the clearest signal to resolve the ambiguity.
Company profile
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry.
CEOJoseph Hogan
SectorHealthcare
IndustryMedical - Devices
Employees21,200
IPO dateJan 30, 2001
Valuation
Forward P/E—
EV/EBITDA13.53
Enterprise value$10.36B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth6.21%
Gross margin67.68%▼2.39%vs FY2024
Operating margin14.44%▲0.51%vs FY2024
ROE10.13%▼7.36%vs FY2024
Analyst consensus
RatingBuy
Target price$203.60▲20.63%
24
Buy
7
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 29, 2026
Q3 FY26 · EPS est $2.61 · Revenue est $1.06B
View